IceCure Medical Announces 1-for-30 Reverse Share Split to Support Nasdaq Compliance
IceCure Medical announced a 1-for-30 reverse share split to regain compliance with Nasdaq's $1.00 minimum bid price requirement. The split reduces outstanding shares from approximately 84.2 million to 2.8 million, with trading on a split-adjusted basis beginning June 4, 2026.
Key figures
- Authorized shares
- 2500000000
- Reverse split ratio
- 1-for-30
- Shares outstanding pre
- 84201034
- Shares outstanding post
- 2806701
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.